Curriculum Vitae

Reza tahvilian

Personal information:

Birth Date: Aug. 15 / 1967
Birthplace:
Isfahan, Iran
Citizenship:
IR. IRAN
Marital status:
Married, two children

Address:           

Dept. of Pharmaceutics

Faculty of Pharmacy and Pharmaceutical Sciences

KermanshahUniversity of Medical Sciences and Health Services (KUMS)
    Phone: 0098-831-4276482
    Fax: 0098-831-4276493
   E-mail: rtahvilian@kums.ac.ir

 

Education :

  • 1981-1985;ShohadayAdab high school Isfahan-IRAN
  • 1986-1993; Faculty of Pharmacy and Pharmaceutical Sciences, I. U. M. S. H. S. (Pharm.D.)
  • 1992; Training in pharmaceutical industry, Daroupakhsh Pharmaceutical Company, Tehran I.R. IRAN
  • 1993-1994; Training in pharmacy practice, ShahidMontazery Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, I. U. M. S. H. S.
  • 1995- April 2002; Dept. of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, I. U. M. S. H. S. (Ph.D)
  • 2002-2003; Sabbatical period at the University of Toronto, Faculty of PharmacyDepartment of Pharmaceutics Dr. X.Y. WU Lab.

 

Employment history:

  • 2004-present; Scientific member of school of pharmacy Kermanshah University of medical sciences (KUMS) as anassistant professor

 Management and superintendence :

  •  2005-2012; vice chancellor of Kermanshah University of Medical Sciences (KUMS),food and drug department
  • 2004-2012; Chief manager of chain pharmacies of Kermanshah University of Medical Sciences
  • Member of research committee of University of Medical Sciences
  • Member of research committee of School of Pharmacy, Kermanshah University of medical Sciences
  • Member of social pharmacy and pharmaceutics committee at secretariats of special pharmaceutics Ministry of Health and Medical Sciences

 Research Activities and Experiences:

Dissertations:

  • 1993 Pharm.D. Thesis; Study of different methods on quality control of a herbal drug used for treating urinary lithiasis (A.U.L.)
  • 1999 Ph.D. Thesis; Preparation of a buccal delivery system of cisapride, evaluation of buccal absorption and comparison of its bioavailability with standard oral dosage form

 

Research projects:

     Pharmaceutical dosage from formulation

             A: Formulation of a herbal tablet named Liquofarcontaining dry extract of liquoric root used for treating pharyngitis
             B: Formulation of melissan gel containing extract of MelissaofficinalisL. for treating herpes simplex
             C: Preparation of syrup fromElaeagnusangustifoliaL.
             D: Preparation and standardization of pure Al(OH)3 powder according to USP from natural sources in IRAN
             E: Clinical study of Oleaster for osteoarthritis
             F: Preparation of a buccal delivery system of cisapride, evaluation of buccal absorption and comparison of its bioavailability with standard oral dosage form
            G: preparation of a buccal delivery system of clotrimazole and physicochemical evaluations
            H: preparation of a buccal delivery system of sumatriptan and physicochemical evaluations
            F: preparation of finastride gel and physicochemical evaluations

 

     Quality control of different dosage forms

  •  A: Quality control of liquofarâtablet (GolDarou Co.)
  •  B: Quality control of melissan gel (GolDarou Co.)

  •  C: Quality control of Oleaster syrup
  •  D: Quality control of Shiraffza drop (a herbal drug used as lactating agent in mothers)

  •  E: Quality control of A.U.L. drop (Sankolâ) (a herbal dosage from used for urinary lithiasis) Quality control of antimigraine drop (a herbal dosage form that used for treating migraine)
  • F: Quality control of antimigraine drop (a herbal dosage form that used for treating migraine)

  Bioavailability and bioequivalancy studies

  • A: Bioequivalancy of A.S.A. 325 mg tablets of Pars Darou Co. with comparison to reference dosage form
  • B: Bioequivalancy of A.S.A. 100 mg tablets of Pars Darou Co. with comparison to reference dosage form
  • C: Bioequivalancy of A.S.A. MC 500 mg tablets of Pars Darou Co. with comparison to reference dosage form
  • D: Bioequivalancy of cisapride10 mg tablets of Sobhan Co. with comparison to reference dosage form
  • E: Bioequvalency of sertraline 100 mg tablets of BakhtarBioshimi Co. with comparison to reference dosage form

 Hospital pharmacy administration and drug dispensing

  • A: Investigate of prescribing and using drugs situation in Imam Reza (a) Hospital (Kermanshah 2010)
  • B: study the management system of drug dispensing in Kermanshah educational hospitals at 2011

  Novel delivery system

 

 


Last Update : Aug 17, 2013 08:50